Bruno Thuillier
Chief Executive Officer
Over his 30-year career, Bruno has helped launch and scale some of the world’s most innovative telecommunication products, mobile phones and sensors. Before co-founding BOYDSense, Bruno was the Chief Technology Officer at Sensitive Object. He also served as Vice President of R&D at Siemens Mobile Phones, and graduated from the Conservatoire National des Arts et Metiers.
Sandrine Isz
Chief Science Officer
With an extensive academic background and 25 years of career research, Sandrine has domain expertise in sensors, nanomaterials, materials chemistry, analytical chemistry, human breath analysis, data mining and artificial intelligence. Her previous experience includes serving as Technical Lead at Merck Prolabo, and completing her post-doctoral studies at Israel’s Weizmann Institute.
Joel Rabasco
VP Product Management
Joel has 25 years of healthcare and technology experience, including in consumer electronics, wireless communications, and healthcare product development. With a BS in mechanical engineering and a master's in international management from UC San Diego, he is an expert at launching new products for startups. Joel has held leadership roles at Qualcomm, Qualcomm Life, Texas Instruments, Siemens Mobile and Hewlett Packard.
Arnaud Debains
Alpha MOS group CFO
Arnaud has experience as a founding CEO of both newly-formed organizations and established companies growing at a rapid pace. He is an expert in the financial challenges faced by companies in high-growth sectors, and is skilled in working in multinational environments, particularly in the telecommunications, Internet and software industries. He has a degree in civil engineering the Ecole Nationale Supérieure des Mines de Saint-Etienne, as well as an MBA from ESSEC Business School in Paris, France.

Advisory Board

Timothy Garvey, MD
Dr. Garvey is Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama. Passionate about healthcare, he has achieved international recognition for his research in the metabolic, molecular and genetic pathogenesis of insulin resistance, Type 2 diabetes and obesity. He graduated cum laude from the Saint Louis University School of Medicine.
Steven Chen, MD
Dr. Chen is an endocrinologist physician with a broad, diverse background including obesity, diabetes and academic clinical research, clinical practice, pharmaceutical clinical development (phase 1-4) and medical affairs. He also has US and global R&D experience with a special focus on China within emerging markets.
William Polonsky, PhD
A globally recognized leader in behavioral health focusing on obesity and diabetes, William is the associate Clinical Professor in Psychiatry at the University of California San Diego. He is an active researcher in the field of behavioral diabetes, and has served on the editorial boards of Diabetes Care, Diabetes Forecast, Clinical Diabetes, Diabetes Self-Management and Diabetes Health.
Donald Jones, MBA, JD
Donald is an internationally recognized leader in digital medicine, digitals therapies and technology-enabled health services. He is an independent director on the boards of venture capital-backed companies including GE, Telus, Qualcomm, Reed Elsevier and Adidas. Donald co-founded Scripps Digital Medicine, the world’s first digital health clinic trial center, and the nonprofit West Health Institute.

An Alpha MOS company, the leader in volatile organic compound analysis.

Our parent company is Alpha MOS, a global provider of gas-compound sensing equipment with over two decades of experience around the world. The team at Alpha MOS includes 25 engineers and scientists. Our diverse backgrounds include biochemistry, biophysics, analytical chemistry, chemical sensors, gas sensing analytics, statistics, mathematics, electronics, and software.  www.alpha-mos.com